Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 79

1.

Selecting empiric antibiotic therapy in an era of multi-drug resistance--is the cupboard really bare? Introduction.

Collatz E.

Clin Microbiol Infect. 2008 Dec;14 Suppl 6:1. doi: 10.1111/j.1469-0691.2008.02127.x. No abstract available.

2.

A plasmid-borne Shewanella algae Gene, qnrA3, and its possible transfer in vivo between Kluyvera ascorbata and Klebsiella pneumoniae.

Lascols C, Podglajen I, Verdet C, Gautier V, Gutmann L, Soussy CJ, Collatz E, Cambau E.

J Bacteriol. 2008 Aug;190(15):5217-23. doi: 10.1128/JB.00243-08. Epub 2008 May 30.

3.

Enzyme structural plasticity and the emergence of broad-spectrum antibiotic resistance.

Maurice F, Broutin I, Podglajen I, Benas P, Collatz E, Dardel F.

EMBO Rep. 2008 Apr;9(4):344-9. doi: 10.1038/embor.2008.9. Epub 2008 Feb 22.

4.

Modes and modulations of antibiotic resistance gene expression.

Depardieu F, Podglajen I, Leclercq R, Collatz E, Courvalin P.

Clin Microbiol Rev. 2007 Jan;20(1):79-114. Review.

5.
6.

An unusual primary sigma factor in the Bacteroidetes phylum.

Vingadassalom D, Kolb A, Mayer C, Rybkine T, Collatz E, Podglajen I.

Mol Microbiol. 2005 May;56(4):888-902.

7.

Fluoroquinolone resistance linked to GyrA, GyrB, and ParC mutations in Salmonella enterica typhimurium isolates in humans.

Casin I, Breuil J, Darchis JP, Guelpa C, Collatz E.

Emerg Infect Dis. 2003 Nov;9(11):1455-7.

8.

Salmonella enterica serovar Typhimurium bla(PER-1)-carrying plasmid pSTI1 encodes an extended-spectrum aminoglycoside 6'-N-acetyltransferase of type Ib.

Casin I, Hanau-Berçot B, Podglajen I, Vahaboglu H, Collatz E.

Antimicrob Agents Chemother. 2003 Feb;47(2):697-703.

9.

An intrinsic control element for translational initiation in class 1 integrons.

Hanau-Berçot B, Podglajen I, Casin I, Collatz E.

Mol Microbiol. 2002 Apr;44(1):119-30.

10.

Crystal structures of the class D beta-lactamase OXA-13 in the native form and in complex with meropenem.

Pernot L, Frénois F, Rybkine T, L'Hermite G, Petrella S, Delettré J, Jarlier V, Collatz E, Sougakoff W.

J Mol Biol. 2001 Jul 20;310(4):859-74.

PMID:
11453693
11.

Multiple mobile promoter regions for the rare carbapenem resistance gene of Bacteroides fragilis.

Podglajen I, Breuil J, Rohaut A, Monsempes C, Collatz E.

J Bacteriol. 2001 Jun;183(11):3531-5.

12.

Antibiotic resistance in salmonellae isolated from humans and animals in France: comparative data from 1994 and 1997.

Breuil J, Brisabois A, Casin I, Armand-Lefèvre L, Frémy S, Collatz E.

J Antimicrob Chemother. 2000 Dec;46(6):965-71.

PMID:
11102416
13.

Role of ser-237 in the substrate specificity of the carbapenem-hydrolyzing class A beta-lactamase Sme-1.

Sougakoff W, Naas T, Nordmann P, Collatz E, Jarlier V.

Biochim Biophys Acta. 1999 Aug 17;1433(1-2):153-8.

PMID:
10446368
14.
15.

Novel OXA-10-derived extended-spectrum beta-lactamases selected in vivo or in vitro.

Mugnier P, Casin I, Bouthors AT, Collatz E.

Antimicrob Agents Chemother. 1998 Dec;42(12):3113-6.

16.

Penicillin-binding protein 5 sequence alterations in clinical isolates of Enterococcus faecium with different levels of beta-lactam resistance.

Rybkine T, Mainardi JL, Sougakoff W, Collatz E, Gutmann L.

J Infect Dis. 1998 Jul;178(1):159-63.

PMID:
9652435
17.

Carbapenems as inhibitors of OXA-13, a novel, integron-encoded beta-lactamase in Pseudomonas aeruginosa.

Mugnier P, Podglajen I, Goldstein FW, Collatz E.

Microbiology. 1998 Apr;144 ( Pt 4):1021-31.

PMID:
9579076
18.

Aminoglycoside 6'-N-acetyltransferase variants of the Ib type with altered substrate profile in clinical isolates of Enterobacter cloacae and Citrobacter freundii.

Casin I, Bordon F, Bertin P, Coutrot A, Podglajen I, Brasseur R, Collatz E.

Antimicrob Agents Chemother. 1998 Feb;42(2):209-15.

19.

Carbapenem resistance in a clinical isolate of Citrobacter freundii.

Mainardi JL, Mugnier P, Coutrot A, Buu-Hoï A, Collatz E, Gutmann L.

Antimicrob Agents Chemother. 1997 Nov;41(11):2352-4.

20.

Surveillance of antibiotic resistance in Salmonella.

Brisabois A, Cazin I, Breuil J, Collatz E.

Euro Surveill. 1997 Mar;2(3):19-20.

PMID:
12631823
21.
22.

A TEM-derived extended-spectrum beta-lactamase in Pseudomonas aeruginosa.

Mugnier P, Dubrous P, Casin I, Arlet G, Collatz E.

Antimicrob Agents Chemother. 1996 Nov;40(11):2488-93.

23.

A rob-like gene of Enterobacter cloacae affecting porin synthesis and susceptibility to multiple antibiotics.

Lee EH, Collatz E, Podglajen I, Gutmann L.

Antimicrob Agents Chemother. 1996 Sep;40(9):2029-33.

24.

[Resistance phenotypes and genotypes of 182 ampicillin-resistant Salmonella Typhymurium strains of human and animal origin.].

Casin I, Brisabois A, Berger N, Breuil J, Collatz E.

Med Mal Infect. 1996 Apr;26 Suppl 3:426-30. French.

PMID:
17292314
25.
27.

Biological and immunological comparisons of Enterobacter cloacae and Escherichia coli porins.

Malléa M, Simonet V, Lee EH, Gervier R, Collatz E, Gutmann L, Pagès JM.

FEMS Microbiol Lett. 1995 Jun 15;129(2-3):273-9.

PMID:
7541759
28.

The H-NS protein is involved in the biogenesis of flagella in Escherichia coli.

Bertin P, Terao E, Lee EH, Lejeune P, Colson C, Danchin A, Collatz E.

J Bacteriol. 1994 Sep;176(17):5537-40.

30.

Synergy and resistance to synergy between beta-lactam antibiotics and glycopeptides against glycopeptide-resistant strains of Enterococcus faecium.

Gutmann L, al-Obeid S, Billot-Klein D, Guerrier ML, Collatz E.

Antimicrob Agents Chemother. 1994 Apr;38(4):824-9.

31.
32.

Novel gyrA point mutation in a strain of Escherichia coli resistant to fluoroquinolones but not to nalidixic acid.

Cambau E, Bordon F, Collatz E, Gutmann L.

Antimicrob Agents Chemother. 1993 Jun;37(6):1247-52.

34.

Analysis of peptidoglycan precursors in vancomycin-resistant enterococci.

Billot-Klein D, Gutmann L, Collatz E, van Heijenoort J.

Antimicrob Agents Chemother. 1992 Jul;36(7):1487-90.

36.
37.

A silent carbapenemase gene in strains of Bacteroides fragilis can be expressed after a one-step mutation.

Podglajen I, Breuil J, Bordon F, Gutmann L, Collatz E.

FEMS Microbiol Lett. 1992 Feb 1;70(1):21-9.

PMID:
1577251
38.

Inducible carboxypeptidase activity in vancomycin-resistant enterococci.

Gutmann L, Billot-Klein D, al-Obeid S, Klare I, Francoual S, Collatz E, van Heijenoort J.

Antimicrob Agents Chemother. 1992 Jan;36(1):77-80.

39.

Association of two resistance mechanisms in a clinical isolate of Enterobacter cloacae with high-level resistance to imipenem.

Lee EH, Nicolas MH, Kitzis MD, Pialoux G, Collatz E, Gutmann L.

Antimicrob Agents Chemother. 1991 Jun;35(6):1093-8.

40.

Characterization of Neisseria meningitidis serogroup A strains from an outbreak in France by serotype, serosubtype, multilocus enzyme genotype and outer membrane protein pattern.

Riou JY, Caugant DA, Selander RK, Poolman JT, Guibourdenche M, Collatz E.

Eur J Clin Microbiol Infect Dis. 1991 May;10(5):405-9.

PMID:
1908380
41.

Mechanisms of quinolone resistance in a clinical isolate of Escherichia coli highly resistant to fluoroquinolones but susceptible to nalidixic acid.

Moniot-Ville N, Guibert J, Moreau N, Acar JF, Collatz E, Gutmann L.

Antimicrob Agents Chemother. 1991 Mar;35(3):519-23.

42.

Nucleotide sequence of the SHV-5 beta-lactamase gene of a Klebsiella pneumoniae plasmid.

Billot-Klein D, Gutmann L, Collatz E.

Antimicrob Agents Chemother. 1990 Dec;34(12):2439-41.

43.
44.

Comparison of vancomycin-inducible proteins from four strains of Enterococci.

al-Obeid S, Gutmann L, Shlaes DM, Williamson R, Collatz E.

FEMS Microbiol Lett. 1990 Jun 15;58(1):101-5.

PMID:
2118867
45.

Mechanism of resistance to vancomycin in Enterococcus faecium D366 and Enterococcus faecalis A256.

al-Obeid S, Collatz E, Gutmann L.

Antimicrob Agents Chemother. 1990 Feb;34(2):252-6.

46.

Outer membrane alteration and resistance to antimicrobial agents.

Gutmann L, Goldstein F, Williamson R, Billot-Klein D, Acar JF, Collatz E.

J Chemother. 1989 Jul;1(4 Suppl):257-8. Review. No abstract available.

PMID:
16312392
47.

SHV-5, a novel SHV-type beta-lactamase that hydrolyzes broad-spectrum cephalosporins and monobactams.

Gutmann L, Ferré B, Goldstein FW, Rizk N, Pinto-Schuster E, Acar JF, Collatz E.

Antimicrob Agents Chemother. 1989 Jun;33(6):951-6.

48.
49.

Mechanisms of beta-lactam resistance in Haemophilus influenzae.

Gutmann L, Williamson R, Collatz E, Acar JF.

Eur J Clin Microbiol Infect Dis. 1988 Oct;7(5):610-5. Review.

PMID:
3143572
50.

The envelope structure of Branhamella catarrhalis as studied by transmission electron microscopy.

Hellio R, Guibourdenche M, Collatz E, Riou JY.

Ann Inst Pasteur Microbiol. 1988 Sep-Oct;139(5):515-25.

PMID:
2472827

Supplemental Content

Loading ...
Support Center